|
|
Registry of biomedical companies:
[3] [4] [7] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 503 active entries
P.O.: 510663 Rm411, Area A, No. 80, Science and Te
Guangzhou City, Guangdong Province, CN
China Phone: 86 20 85653352 Fax: 86 20 85653397
Description:
Excenen PharmaTech is a high-tech research company dedicated in new molecules research and development for pharmaceutical enterprises, biochemical companies, medicinal research institutes, universities.
Our featured compounds: Acumapimod (BCT-197) | 836683-15-9 | SGC2085 | 1821908-48-8 | WIKI4 | 838818-26-1 | | | TCS OX2 29 | 372523-75-6 | Stattic | 19983-44-9 | | | S0859 | 1019331-10-2 | Cyantraniliprole | 736994-63-1 | CZ415 | 1429639-50-8 | ID-8 | 147591-46-6 | PLX8394 | 1393466-87-9 | Cloethocarb | 51487-69-5 | Morantel Citrate | 69525-81-1 | SCH58261 | 160098-96-4 | RO0921 | 1446790-62-0 | OTS514 | 1338540-63-8 | OTS964 | 1338545-07-5 | Ochratoxin-A | 1448049-50-0 | BTB06584 | 219793-45-0 | AG 555 | 133550-34-2 | AZD3293 | 1383982-64-6 | MLN 4924 | 905579-51-3 | BGB-283 | 1446090-77-2 | GNE-140 | 2003234-63-5 | T006 | 1415666-63-5 | Eniporide | 176644-21-6 | N-(5-bromo-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide | 1086063-46-8 | 1-(4-fluorobenzoyl)cyclopropanecarboxylic acid | 1191284-11-3 | Benzamide, 4-methyl-N-(methylsulfonyl)- (9CI) | 827624-81-7 | Idrocilamide | 6961-46-2 | CEP-32496 (free base) | 1188910-76-0 | SGX-523 | 1022150-57-7 | MSDC-0160(CAY10415) | 146062-49-9 | (S)-6-bromo-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide | 1346574-54-6 | T003 | 1414378-14-5 | 2-(4-((9S,13S)-9,13-Bis(Tert-Butoxycarbonyl)-18,18-Dimethyl-3,11,16-Trioxo-17-Oxa-2,4,10,12-Tetraazanonadecyl)Phenyl)Acetic Acid | 1610413-97-2 | 3-[(6,7-dimethoxy-4-quinazolinyl)oxy]aniline | 1188908-37-3 | Levofloxacin | 100986-85-4 | Pentamidine-d4 2HCl | 50357-45-4 | FR180204 | 865362-74-9 | BAY 11-7082 | 19542-67-7 | WZB117 | 1223397-11-2 | 3-(Methoxymethoxy)propanal | 109066-05-9 | 1,1,2,2-Tetraphenylethene | 632-51-9 | CY3.5 | 1284240-77-2 | CY5.5 | 210892-23-2 | CY7 | 943298-08-6 | Dimebolin | 3613-73-8 | HA-1100 | 105628-72-6 | MG-132 | 133407-82-6 | UNC3866 | 1872382-47-2 | BV6 | 1001600-56-1 | MM-102 | 1417329-24-8 | ZINC00881524 (ROCK inhibitor) | 557782-81-7 | VH-298 | 2097381-85-4 | VcMMAE | 646502-53-6 | SC-560 | 188817-13-2 | 3-TYP | 120241-79-4 | Belizatinib (TSR011) | 1357920-84-3 | H3B-6527 | 1702259-66-2 | Lanifibranor | 927961-18-0 | MBX-8025 (Seladelpar) | 851528-79-5 | SGI-7079 | 1239875-86-5 | BI-882370 | 1392429-79-6 | Brequinar | 96187-53-0 | CBP-307 | N/A | PST2744 | 203737-93-3 | SCR-1438 | 1174046-76-4 | TP353 | 1253799-29-9 | CG347B | 1598426-03-9 | CPFX2090 | 1429439-25-7 | CPFX1302 | N/A | LSP-249 | 1801253-04-2 | ACT-1002-1237 | N/A | ZN2007-RM1 | N/A | TBAJ-587-1 | N/A | TP-4748 | 1150114-62-7 | CG378P | N/A | CG378M | N/A | TP748 | 951698-15-0 | THZ2 | 1604810-84-5 | THZ531 | 1702809-17-3 | FM-381 | N/A | INNO-406 | 859212-16-1 | IOX4 | 1154097-71-8 | GDC-0941 | 957054-30-7 | Autophinib | 1644443-47-9 | NG25 | 1315355-93-1 | SNS-062 | 1270014-40-8 | AcycloA | 31383-66-1 | CEP-28122 | 1022958-60-6 | Elvitegravir | 697761-98-1 | CEP-37440 | 1391712-60-9 | GSK2334470 | 1227911-45-6 | HA130 | 1229652-21-4 | AM281 | 202463-68-1 | AM630 | 164178-33-0 | AZD7762 | 860352-01-8 | AZD8055 | 1009298-09-2 | BGJ-398,NVP-BGJ398,Infigratinib | 1310746-10-1 | BMS-911543 | 1271022-90-2 | CEP-32496 HCl salt | 1227678-26-3 | CH5424802 HCl salt, Alectinib HCl salt, AF802 HCl salt | 1256589-74-8 | Cilomilast, SB 207499, Ariflo | 153259-65-5 | CUDC-305, Debio 0932 | 1061318-81-7 | Erismodegib Diphosphate, NVP-LDE225 (diphosphate salt) | 1218778-77-8 | GDC-0941 bimesylate salt, Pictilisib dimethanesulfonate | 957054-33-0 | GNE-317 | 1394076-92-6 | GSK2118436 Ms salt, Dabrafenib Ms salt, GSK2118436A Ms salt | 1195768-06-9 | HSP990, NVP-HSP990 | 934343-74-5 | I-BET151 (GSK1210151A) | 1300031-49-5 | IPI-145, INK 1197, Duvelisib | 1201438-56-3 | LDK378 dihydrochloride, Ceritinib dihydrochloride | 1380575-43-8 | Mavoglurant, AFQ056 | 543906-09-8 | MI-2, Menin-MLL inhibitor 2 | 1271738-62-5 | MK-2461 | 917879-39-1 | NVP-BKM120 HCl salt | 1312445-63-8 | TAK-960 HCl salt | 1137868-96-2 | Talampanel, GYKI-53773; LY-300164 | 161832-65-1 | VX-11e | 896720-20-0 | XL388 | 1251156-08-7 | LGB-321 | 1210417-75-6 | Afuresertib HCl salt, GSK-2110183 HCl salt, GSK-2110183B HCl salt | 1047645-82-8 | Afuresertib, GSK-2110183, GSK-2110183B | 1047644-62-1 | AMG 511 | 1253573-53-3 | AZD0530, Saracatinib | 379231-04-6 | AZD9291 Ms salt, Osimertinib Ms salt; Mereletinib Ms salt | 1421373-66-1 | AZD4547 | 1035270-39-3 | Dinaciclib (SCH 727965) | 779353-01-4 | Decernotinib,VX-509 | 944842-54-0 | GDC-0032, Taselisib; RG-7604 | 1282512-48-4 | A-1210477 | 1668553-26-1 | EPZ011989 | 1598383-40-4 | CO-1686 HBr salt,Rociletinib HBr salt; AVL-301 HBr salt, CNX-419 HBr salt | 1446700-26-0 | LEE-011 HCl salt, Ribociclib HCl salt | 1211443-80-9 | LEE-011 succinate salt, Ribociclib succinate salt | 1374639-75-4 | LGX818, Encorafenib | 1269440-17-6 | LY2835219 Ms salt, Abemaciclib Ms salt | 1231930-82-7 | MK-0731 | 845256-65-7 | NMS-1286937,NMS-P937 | 1034616-18-6 | P505-15 HCl salt, PRT062607 HCl salt,PRT-2607 HCl salt, BIIB-057 HCl salt | 1370261-97-4 | P505-15, PRT062607,PRT-2607, BIIB-057 | 1370261-96-3 | Uprosertib , GSK2141795 | 1047634-65-0 | Uprosertib HCl salt, GSK2141795 HCl salt | 1047635-80-2 | WEHI-539 ( CT-WE539) | 1431866-33-9 | XL-228 | 898280-07-4 | AZD3147 | 1101810-02-9 | CCT196969 | 1163719-56-9 | Danusertib, PHA-739358 | 827318-97-8 | EPZ011989 TFA salt | 1598383-41-5 | EPZ020411 | 1700663-41-7 | Oclacitinib,PF-03394197 | 1208319-26-9 | PFI-2 | 1627676-59-8 | PFI-2 HCl salt | 1627607-87-7 | AG-881,Mutant IDH1-IN-2 | 1429176-69-1 | BAY-1436032 | 1803274-65-8 | CCT-245737 | 1489389-18-5 | Cenicriviroc | 497223-25-3 | CFI-400945, | 1338806-73-7 | CHZ868 | 1895895-38-1 | CNDAC | 135598-68-4 | CPI-0610 | 1380087-89-7 | EPZ031686 | 1808011-22-4 | GDC-0994 | 1453848-26-4 | I-181 | N/A | PF-2771 | N/A | Sapacitabine | 151823-14-2 | Selonsertib HCl salt, GS-4997 HCl salt | 1448428-05-4 | LX1606 Hippurate, Telotristat Etiprate | 1137608-69-5 | Telotristat, LP778902 | 1033805-28-5 | CH5424802 analog | 1256577-71-5 | GSK-923295 8R-ISOMER | N/A | AMG 511 RACEMATES | N/A | AZD5363 RACEMATE | N/A | CEP-37440 R-ISOMER | N/A | | | GS-9901 R-ISOMER | N/A | Upadacitinib, ABT-494 | 1310726-60-3 | D- Luciferin Potsossium salt | 115144-35-9 | Lonafarnib | 193275-84-2 | NVP-HDM201; HDM201 | 1448867-41-1 | S-63845 | 1799633-27-4 | APD334 | 1206123-37-6 | CCT251236 | 1693731-40-6 | AF-353 | 865305-30-2 | MK 0557 | 328232-95-7 | Tandutinib | 387867-13-2 | LY3009120 | 1454682-72-4 | I-BRD9 | 1714146-59-4 | EGF816 | 1508250-71-2 | GSK-3326595;EPZ-015938 | 1616392-22-3 | Dovitinib lactate(TKI258) | 915769-50-5 | Niraparib tosylate | 1038915-73-9 | Cariprazine hydrochloride | 1083076-69-0 | TGR1202 | 1532533-67-7 | GLPG1690 | 1628260-79-6 | PTC-028 | 1782970-28-8 | Takinib | 1111556-37-6 | AZD8186 | 1627494-13-6 | LGD-6972 | 1207989-09-0 | KDM5-C70 | 1596348-32-1 | BI-9564 | 1883429-22-8 | | | Lasmiditan succinate | 439239-92-6 | TLR7-IN-1 | 1642857-69-9 | ACC-789 | 300842-64-2 | BMT-145027 | 2018282-44-3 | GDC-0152 | 873652-48-3 | Emricasan | 254750-02-2 | PF-05175157 | 1301214-47-0 | Naloxegol Oxalate | 1354744-91-4 | BAY 1895344 | 1876467-74-1 | Epoxomicin | 134381-21-8 | TAPI-1 | 171235-71-5 | Trichostatin A (TSA) | 58880-19-6 | L-BMAA HCl | 15920-93-1 | TAPI-2 | 187034-31-7 | XL888 | 1149705-71-4 | PF1022A | 133413-70-4 | Ruxolitinib | 941678-49-5 | Batimastat(BB-94) | 130370-60-4 | LGD3303 | 917891-35-1 | ARN-3236 | 1613710-01-2 | Itacitinib; INCB039110 | 1334298-90-6 | Upadacitinib tartrate | 1607431-21-9 | Fluxapyroxad | 907204-31-3 | Tacrolimus | 104987-11-3 | Ectoine | 96702-03-3 | M-3814 | 1637542-33-6 | LY-3200882 | 1898283-02-7 | AZD-4635 | 1321514-06-0 | CNDAC HCl | 134665-72-8 | Umeclidinium bromide | 869113-09-7 | CPI-169 R-enantiomer | 1802175-07-0 | ML216 | 1430213-30-1 | RG7112 | 939981-39-2 | RSV604 | 676128-63-5 | TD139 | 1450824-22-2 | ARS853 | 1629268-00-3 | EC330 | 2016795-77-8 | (2R,3S)-rel-2,3-Bis(4-chlorophenyl)butane-2,3-diamine | 939983-16-1 | 5-bromo-4-chloro-6-iodothieno[2,3-d]pyrimidine | 1799610-89-1 | Thiazovivin | 1226056-71-8 | GSK1349572 sodium salt | 1051375-19-9 | GSK1349572 | 1051375-16-6 | MCB-613 | 1162656-22-5 | Lorcaserin hydrochloride | 846589-98-8 | PU-WS13 | 1454619-14-7 | methyl 5-ethyl-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxylate | 1354639-60-3 | Amenamevir | 841301-32-4 | MK-801 (Dizocilpine) | 77086-21-6 | GSK-F1 | 1384097-27-1 | TTA-A2 | 953778-63-7 | CMP8 | 851107-28-3 | CLR1501 | 1250963-36-0 | Benzamil hydrochloride | 161804-20-2 | iCRT-14 | 677331-12-3 | XCT790 | 725247-18-7 | Rhodamine 123 | 62669-70-9 | LY-294002 hydrochloride | 934389-88-5 | AP-1903 | 195514-63-7 | Troparil | 74163-84-1 | 3-(3,5-dimethoxyphenethyl)-1H-pyrazol-5-amine | 1000895-53-3 | LY2857785 | 1619903-54-6 | Delpazolid | 1219707-39-7 | | | | | 80% of avbove listed items are kept in stock. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Product Company |
|
Service Company |
- Biopharma
- - Research
- Biotech
- - Research
- Pharmaceutical
- - Research
- Supplier
- - Laboratory
- - Research
|
|
|
Last update of this entry: October 03, 2019
|